Skip to main content
. 2018 Sep 17;8:13883. doi: 10.1038/s41598-018-32306-4

Table 2.

Patients’ information.

Sample code Age Gender WHO 2016 Karyotype IPSS-R % Blasts BM
#1 76 M CMML-1 46,XY[20] N/A 1
#5 83 M MDS-EB-1 47,XY, +8[3]/46,XY[28] High 7
#6 46 F RS-MLD 46,XX[20] Low 2
#9 70 F RS-MLD 46,XX[20] Int 4
#10 74 M MDS-EB-2 45,X, −Y,del(1)(p13p32),der(11)t(Y;11)(q11;q13)[8]/46,XY[12] Very high 12
#12 73 F MDS with isolated del(5q) 46,XX,del(5)(q22q33)[15]/46,XX[5] Low 2
#14 72 M CMML-0 46,XY,del(5)(q31q33)[6] N/A 0
#15 51 M MLD N/A (normal FISH 5p15.2, 5q31, 7q31 & 20q12) N/A 2
#16 59 F CMML-0 46,XX[20] N/A 2
#17 79 M CMML-2 46,XX[20] N/A 13
#20 52 M CMML-1 46,XY[20] N/A 4
#23 71 F MDS with isolated del(5q) 46 XX, −11, +mar [20] Int 3
#24 29 F MDS isolated del(5q) 46,XX,del(5)(q12q32)[11]/46,XX[9] N/A N/A
#26 81 F MLD 46,XX[10] Low 0
#27 59 F MDS with isolated del(5q) 46,XX,del(5)(q13q33)[4]/46,XX[15] Low 2
#28 65 M RS-MLD 46,XY[20] Very low 2
#29 86 F MLD 47,XX, +8[10]/48,idem, +mar[2]/46,XX[7] High 3
#30 65 M RS-MLD 46,XY[20] Very low 2
#31 71 M MDS with isolated del(5q) 46,XY,del(5)(q14q34)[8]/46,XY[22] Low 7
#32 78 M MDS with isolated del(5q) 46,XY,del(5)(q13q33)[12]/46,XY[8] Very low 2
#33 77 M MDS-EBS2 Complex Very high >5%
#34 67 M MDS-MLD 46,XY[20] Low 4
#35 78 F MDS-RS 46,XX[20] Very low 0
#36 60 M CMML-1 N/A N/A 0
#37 60 F RS-MLD 46,XX[20] Very low 1
#38 91 M MDS-EB-1 45,X, −Y[14]/46,XY[6] Int 7
#39 70 F CMML-1 46,XX[20] N/A 1
#40 67 M MDS-EB-2 43,XY, −5,der(13;14)(q10;q10),add(15)(p10),add(16)(q24), −17,add(17)(p13), −18, +mar[cp14] Very high 15
#41 71 M CMML-0 46,XX[20] N/A 0
#43 83 M MDS-MLD 46,XY[20] Very low 1
#49 67 F MDS-EB1 26/08/2015: 46,XX,del(5)(q11q31)[15] Low 8
#50 75 M MDS-MLD 47,XY, +21[5]/46,XY[15 Low 2,5
#52 78 F MDS-MLD 46,XX,del(5)(q22q35),del(11)(q13.1q23.3)[17]/46,XX[3] Low 3,5
#53 56 M MDS-MLD 46,XY[20] Low 2
#57 79 M MDS-EB-1 46,XY[21] Int 5
#60 80 F MDS with isolated del(5q) 46,XX,del(5)(q13)[11]/46,XX[9] Low 4
#68 94 F MDS with isolated del(5q) 46,XX,del(5)(q13q33)[9]/46,XX[24] Very low 1
#73 76 M CMML-0 46,XY[20] Very low 1,5
#74 80 M MDS-MLD 46,XY[20] Low 0
#76 83 F MDS-MLD del(5q) Low <5
#78 73 F MDS-MLD 46,XX,add(9)(p24),16qh+c[7]/46,XX,16qh+c[7] Low <2
#80 67 F CMML-2 46,XX[20] Int 13
#93 79 F RS-SLD with thrombocytosis N/A Low 1
#95 66 M CMML-0 46,XY,t(4;16)(q21;q24)[3]/47,sl, +8[17] N/A 0
#98 63 F MDS with isolated del(5q) del(5q) add(7) Low 1
#103 70 M CMML-1 46,XY[20] N/A N/A
#110 80 M CMML-1 46,XY[20] N/A N/A
#113 56 M CMML-1 47,XY, +8[14]/46,XY[3] N/A N/A
#119 53 F MDS-EB1 46,XX,del(5)(q14q33)[7]/46,XX [13] Int 7,8
#122 N/A F CMML-1 47,XX, +21[13] N/A N/A
#131 68 F MDS-MLD 46,XX[20] Very low 0
#132 72 M MDS-MLD 46,XY[20] Very low <2
#134 45 M MDS-MLD 46,XY[20] Low 1
#138 68 F MDS-MLD 46,XX,del(5)(q13q33),del(11)(q13q23) Low 1
#140 69 F MDS-RS-SLD (−7) N/A N/A
#143 69 M MDS/MPN (MDS/MPN-RS-T) 46,XY[13] Low <2
#145 83 M MLD 45,X, −Y[18]/46,XY[2] Low 3
#149 64 F MDS with isolated del(5q) 46,XX del(5)(q15q33)[20] Low 1,6
#151 53 F MDS-EB2 N/A High 12
#154 79 F MDS-EB-1 46,XX[20] Int 6
#161 69 M CMML-1 46,XY[20] N/A N/A
#162 54 M MDS-EB2 46,XY,t(16;17)(q24;q22) Very high 12
#166 73 M MDS-MLD 46,XY[2] Low 2
#170 58 M MDS-SLD 46,XY,inv(2)(p23q13),del(5)(q13q32) Low 1
#176 70 F MDS-MLD 46,XX[20] Very low 1
#181 73 F MDS-MLD 46,XX,add(9)(p24),16qh+c[7]/46,XX,16qh+c[7] Low <2
#186 62 M MDS-MLD 45,X,(−Y)[10]/46,XY[1] Very low 1
#187 84 F MDS-MLD 46,XX[14] Very low 2,1
#188 80 M MDS-MLD 46,XY[20] Low 0
#195 72 M MDS-MLD 46,XY[20] Very Low <2
#197 N/A M CMML N/A N/A N/A
#210 59 F MDS with isolated del(5q) 46,XX,del(5)(q22q31–32)[5]/46,XX[15] Low 2
#211 75 F MLD 46,XX, −5, −14, +mar1, +mar2[16]/45,XX,del(5)(q13q33), −6[2]/46,XX[8] High 1
#212 66 M CMML-0 46,XY[20] N/A 4
#213 83 F MDS-EB-1 del(7)(q22q31) Very high 5
#214 30 F MLD 46,XX[20] Vey low 2

M, male; F, female. Int, intermediate. N/A, not available.